25th October 2014                                                                                                                                                        
Home / Top Headlines / FDA Approves 18 Drugs from Pharma Company Accused of Fraud and Conspiracy

FDA Approves 18 Drugs from Pharma Company Accused of Fraud and Conspiracy

By David Gutierrez

The FDA has approved 18 products for market from generic drug manufacturer Ranbaxy Laboratories, even though the company is currently being investigated by Congress for making substandard products and conspiring to fraudulently cover it up.

“Allegations from reliable sources and supporting documents indicate a pattern of systemic fraudulent conduct, including submissions by Ranbaxy to the FDA that contain false and fabricated information,” the Department of Justice said.

The Department of Justice is investigating claims that Ranbaxy, India’s largest drug manufacturer, produced HIV medication that contained insufficient active ingredients or was adulterated with other ingredients. These drugs were then used to treat patients in Africa.

Other drugs are also suspected of containing active ingredients in concentrations that are either too low or too high. The company also stands accused of attempting to conceal manufacturing procedures that do not meet FDA standards and of forging documents relating to U.S. government investigations of its practices.

Finally, Ranbaxy is being investigated for falsifying data suggest that its generic drugs are absorbed into the body in a similar fashion to brand-name products. This proof is an essential part of the process of gaining FDA approval for a generic drug without going through large clinical trials.

In July, Congress also began a probe into why the FDA had not taken action against Ranbaxy, even though it had known for months of allegations against the company. As part of this probe, the FDA was asked to provide information on every FDA-approved Ranbaxy product and the approval process that it went through.

Former FDA Deputy Commissioner Mary Pendergast has criticized the FDA’s failure to take action against Ranbaxy and its products.

Because the FDA “wouldn’t be confident of the accuracy and reliability of the information in the applications,” Pendergast said, “they might be approving a product that ought not be approved.”

  • http://www.hotelswati.com/ Delhi Hotels

    On the verge of bankruptcy, Connelly sold MET-Rx to the Shansby Group for $10 million. Shansby turned around and sold it for $108m to Rexall Sundown in 1999. Scott Connelly resurfaced only to fail miserably, attempting to sell protein enriched dog food, K9-Rx, using his signature, shirtless ab-shot next to fido – how weird is that?

  • http://biotechnologynetwork.wordpress.com/2012/01/03/biotech-startups/ biotech startups

    There are many people who use the drug license in an illegal manner. Government should keep an eye on such companies and cancelled their license so that they don’t play with the health of people.

Why RINF is different... And why you need to watch this...

RINF not only delivers the info you're not supposed to know, but also provides 100% free solution based videos and articles designed to help you to :

  • Improve your overall health
  • Get more financial independence
  • Stay informed & ahead of the curve
  • Become less dependent on corporations